| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.3 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |